133 related articles for article (PubMed ID: 17610148)
1. The dominant-negative action of a fusion protein containing the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein gp41 in virus replication.
Chan WE; Chen SS
J Biomed Sci; 2007 Nov; 14(6):717-29. PubMed ID: 17610148
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of human immunodeficiency virus type 1 Gag expression by a gp41 cytoplasmic domain fusion protein.
Chan WE; Chen SS
Virology; 2006 May; 348(2):418-29. PubMed ID: 16472834
[TBL] [Abstract][Full Text] [Related]
3. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.
Chen SS; Lee SF; Wang CT
J Virol; 2001 Oct; 75(20):9925-38. PubMed ID: 11559825
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to virus-cell fusion at the plasma membrane is reduced through expression of HIV gp41 cytoplasmic domains.
Malinowsky K; Luksza J; Dittmar MT
Virology; 2008 Jun; 376(1):69-78. PubMed ID: 18400243
[TBL] [Abstract][Full Text] [Related]
5. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
Welman M; Lemay G; Cohen EA
Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity.
Chen SS; Ferrante AA; Terwilliger EF
Virology; 1996 Dec; 226(2):260-8. PubMed ID: 8955046
[TBL] [Abstract][Full Text] [Related]
7. Analysis of dominant-negative effects of mutant Env proteins of human immunodeficiency virus type 1.
Iwatani Y; Kawano K; Ueno T; Tanaka M; Ishimoto A; Ito M; Sakai H
Virology; 2001 Jul; 286(1):45-53. PubMed ID: 11448157
[TBL] [Abstract][Full Text] [Related]
8. Mutations of conserved glycine residues within the membrane-spanning domain of human immunodeficiency virus type 1 gp41 can inhibit membrane fusion and incorporation of Env onto virions.
Miyauchi K; Curran R; Matthews E; Komano J; Hoshino T; Engelman DM; Matsuda Z
Jpn J Infect Dis; 2006 Apr; 59(2):77-84. PubMed ID: 16632906
[TBL] [Abstract][Full Text] [Related]
9. Effect of extension of the cytoplasmic domain of human immunodeficiency type 1 virus transmembrane protein gp41 on virus replication.
Chan WE; Wang YL; Lin HH; Chen SS
J Virol; 2004 May; 78(10):5157-69. PubMed ID: 15113898
[TBL] [Abstract][Full Text] [Related]
10. The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120.
Day JR; Van Damme N; Guatelli JC
Virology; 2006 Oct; 354(2):316-27. PubMed ID: 16905171
[TBL] [Abstract][Full Text] [Related]
11. Luman, a new partner of HIV-1 TMgp41, interferes with Tat-mediated transcription of the HIV-1 LTR.
Blot G; Lopez-Vergès S; Treand C; Kubat NJ; Delcroix-Genête D; Emiliani S; Benarous R; Berlioz-Torrent C
J Mol Biol; 2006 Dec; 364(5):1034-47. PubMed ID: 17054986
[TBL] [Abstract][Full Text] [Related]
12. Assembly of HIV GAG-B-galactosidase fusion proteins into virus particles.
Wang CT; Stegeman-Olsen J; Zhang Y; Barklis E
Virology; 1994 May; 200(2):524-34. PubMed ID: 8178440
[TBL] [Abstract][Full Text] [Related]
13. Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein.
Ye L; Sun Y; Lin J; Bu Z; Wu Q; Jiang S; Steinhauer DA; Compans RW; Yang C
Virology; 2006 Aug; 352(1):74-85. PubMed ID: 16725170
[TBL] [Abstract][Full Text] [Related]
14. Sequence requirements for incorporation of human immunodeficiency virus gag-beta-galactosidase fusion proteins into virus-like particles.
Wang CT; Lai HY; Yang CC
J Med Virol; 1999 Oct; 59(2):180-8. PubMed ID: 10459153
[TBL] [Abstract][Full Text] [Related]
15. Recombinant proteins derived from immunodominant regions of the gag and env genes of HIV-1 and their potential for use in serologic diagnosis.
Kovác J
Acta Virol; 1991 Aug; 35(4):383-90. PubMed ID: 1686963
[TBL] [Abstract][Full Text] [Related]
16. Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly.
Lambelé M; Labrosse B; Roch E; Moreau A; Verrier B; Barin F; Roingeard P; Mammano F; Brand D
J Virol; 2007 Jan; 81(1):125-40. PubMed ID: 17050592
[TBL] [Abstract][Full Text] [Related]
17. Dominant-negative effect of hetero-oligomerization on the function of the human immunodeficiency virus type 1 envelope glycoprotein complex.
Herrera C; Klasse PJ; Kibler CW; Michael E; Moore JP; Beddows S
Virology; 2006 Jul; 351(1):121-32. PubMed ID: 16616288
[TBL] [Abstract][Full Text] [Related]
18. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
Affranchino JL; González SA
Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
[TBL] [Abstract][Full Text] [Related]
19. Identification of the LWYIK motif located in the human immunodeficiency virus type 1 transmembrane gp41 protein as a distinct determinant for viral infection.
Chen SS; Yang P; Ke PY; Li HF; Chan WE; Chang DK; Chuang CK; Tsai Y; Huang SC
J Virol; 2009 Jan; 83(2):870-83. PubMed ID: 18987155
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity.
Murakami T; Ablan S; Freed EO; Tanaka Y
J Virol; 2004 Jan; 78(2):1026-31. PubMed ID: 14694135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
